600196 Shanghai Fosun Pharmaceutical
- 22.50
- -0.13-0.57%
Shanghai Fosun Pharmaceutical News
Announcement on Employee Supervisor Change by Fosun Pharma
Announcement of Fosun Pharma Regarding its Holding Subsidiary's Acceptance of Pharmaceutical Registration Application
Fosun Pharmaceutical's announcement on foreign investment and relinquishment of priority subscription rights
Fosun Pharmaceutical's announcement on the approval of its holding subsidiary for drug registration
Announcement of Fosun Pharmaceutical on the acceptance of drug registration applications by holding subsidiaries
Information on the 2023 Annual General Meeting of Shareholders of Fosun Pharmaceutical, the first Class A Shareholders' Meeting in 2024, and the first Class H Shareholders' Meeting in 2024
Notice of Fosun Pharmaceutical on holding the 2023 Annual General Meeting of Shareholders, the First Class A Shareholders' Meeting in 2024, and the First Class H Shareholders' Meeting in 2024
Announcement of Fosun Pharmaceutical on the acceptance of drug registration applications by holding subsidiaries
Fosun Pharmaceutical's announcement that its holding subsidiary has been approved for a supplementary drug application
Fosun Pharmaceutical's announcement on the progress of the licensing agreement for its holding subsidiary
Fosun Pharmaceutical's announcement on the signing of a capital increase and stock expansion agreement by its holding subsidiary
Fosun Pharmaceutical's announcement on amending the “Articles of Association” and its annexes
Announcement of Fosun Pharmaceutical on the approval of its holding subsidiary for drug clinical trials
Fosun Pharmaceutical's announcement on the approval of its holding subsidiary for drug registration
Fosun Pharmaceutical's announcement that its holding subsidiary has been approved for clinical trials of drugs by the US FDA
Fosun Pharmaceutical's announcement on the approval of its holding subsidiary for drug registration
Fosun Pharmaceutical's announcement on the completion of private equity fund filing for investment funds participating in the establishment
Announcement of Fosun Pharmaceutical on the approval of its holding subsidiary for drug clinical trials
Announcement of Fosun Pharmaceutical on the acceptance of drug registration applications by holding subsidiaries
Announcement of Fosun Pharmaceutical on the acceptance of drug registration applications by holding subsidiaries
Analysis
Price Target
No Data
